| Dr Mohammad Ali Khan, MD | |
|
7741 Belle Point Drive, Greenbelt, MD 20770 | |
| (301) 345-3152 | |
| (301) 345-3182 |
| Full Name | Dr Mohammad Ali Khan |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 51 Years |
| Location | 7741 Belle Point Drive, Greenbelt, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487611059 | NPI | - | NPPES |
| 187402100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | D0023242 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umd Prince George's Hospital Ctr | Cheverly, MD | Hospital |
| Entity Name | Dimensions Healthcare Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346354834 PECOS PAC ID: 1557269743 Enrollment ID: O20031226000032 |
News Archive
Researchers in China have developed tiny nanocrystals that could be used in the next generation of medical imaging technologies to light up cancer cells.
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
What makes the coronavirus disease (COVID-19) global pandemic different from the Spanish flu in 1918? In 1918, transportation, technology, and science were in their infancy, with the medical field not capable of fighting outbreaks. Technology has come a long way, within days, scientists have already identified the type of virus spreading in China, and three months after, vaccine trials have started.
The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohammad Ali Khan, MD 7741 Belle Point Drive, Greenbelt, MD 20770 Ph: (301) 345-3152 | Dr Mohammad Ali Khan, MD 7741 Belle Point Drive, Greenbelt, MD 20770 Ph: (301) 345-3152 |
News Archive
Researchers in China have developed tiny nanocrystals that could be used in the next generation of medical imaging technologies to light up cancer cells.
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
What makes the coronavirus disease (COVID-19) global pandemic different from the Spanish flu in 1918? In 1918, transportation, technology, and science were in their infancy, with the medical field not capable of fighting outbreaks. Technology has come a long way, within days, scientists have already identified the type of virus spreading in China, and three months after, vaccine trials have started.
The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
› Verified 9 days ago
Ratna M. Kunasani, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 7300 Hanover Dr Ste 104, Greenbelt, MD 20770 Phone: 301-486-4690 Fax: 301-441-8809 | |
Dr. Brajendra Nath Misra, M.D.,M.S.,F.A.C.S Surgery Medicare: Medicare Enrolled Practice Location: 7220 Hanover Pkwy, Suite A, Greenbelt, MD 20770 Phone: 301-220-0088 Fax: 301-220-1005 | |
Dr. Etwar H Mcbean, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7500 Greenway Center Dr Ste 1120, Greenbelt, MD 20770 Phone: 240-206-8506 Fax: 240-929-6978 | |
Dr. Gustavo Restrepo, MD Surgery Medicare: Medicare Enrolled Practice Location: 8955 Edmonston Rd, Suite I, Greenbelt, MD 20770 Phone: 301-441-9410 Fax: 301-345-6671 | |
Dr. Said Abolghassem Daee, MD Surgery Medicare: Medicare Enrolled Practice Location: 7525 Greenway Center Dr, Suite 309, Greenbelt, MD 20770 Phone: 301-220-0099 Fax: 301-220-0308 | |
Vijayan Charles, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 7237 Hanover Pkwy Ste B, Greenbelt, MD 20770 Phone: 301-982-4892 Fax: 301-982-5813 |